Position in TGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,618,925
+$13,273,719 QoQ
Shares Held
429,904
+38.0% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#41
of 426 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $349,256,528 across 27 Biotechnology names. TGTX ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
455,392 | $48,553,895 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
463,146 | $36,250,437 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
448,143 | $33,377,690 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
51,333 | $32,008,178 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
99,584 | $29,977,771 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
This page
|
429,904 | $23,618,925 | |
| 7 | EXEL |
Exelixis, Inc.
|
400,859 | $21,810,738 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
54,489 | $20,251,926 |
All Filings in TGTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,618,925 | 429,904 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,345,206 | 311,415 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,006,377 | 469,855 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,360,132 | 342,149 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||